Event-Driven Stocks

PMGC Holdings Inc.

ELABNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 2 good● 2 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22
Revenue$590,084—$1.7M$766,277
Operating income————
Net income−$7.7M−$6.2M−$4.3M−$1.8M
Total assets$12.9M$9.0M$5.2M$1.9M
Total liabilities$5.0M$2.3M$1.4M$760,873
Equity$7.8M$6.7M$3.8M$1.1M
EPS (diluted)——$-0.40$-0.19
Shares out.707,10617.3M17.3M9.6M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
—
Net margin
−1313.0%
Return on equity
−98.9%
Return on assets
−60.2%
Return on capital (ROCE)
—
Liabilities / assets
39.1%
Debt / equity
0.64×
Book value / share
$11.08
Revenue growth (YoY)
—
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Accruals / assets
−14.1%clean
Piotroski F-Score
3/7weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
59
/ 100
Profitability 0Growth n/aCatalyst 67Earnings quality 67Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 2 warning● 2 good
  • Reported a net loss
  • Negative operating cash flow
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
2 acquisitions1 disposalsnet +5.5M shares · last 3
InsiderDateTypeSharesPrice
Bensler GraydonOfficer — CEO &amp; CFOMar 26, 2025Grant3.0M$0.00
Braeden LichtiDirectorMar 26, 2025Grant3.3M$0.00
Bwl Investments Ltd.10% ownerDec 28, 2023J828,000$0.00

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 2026385,4031.0+63.2%
Apr 30, 2026236,1861.0-43.0%
Apr 15, 2026414,5061.0-74.8%
Mar 31, 20261.6M1.0+4866.1%
Mar 13, 202633,0601.0-61.9%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.